NCT05508087 - Cardiovascular Diagnostic in Assessment of Risk HDS and HCT in Patients With Haemoblasts. | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

July 17, 2019

Primary Completion Date

March 1, 2025

Study Completion Date

July 10, 2025

Conditions

Cardiotoxicity

Interventions

DIAGNOSTIC_TEST

electrocardiography, echocardiography with the determination of global longitudinal strain, cardiopulmonary exercise test, and diagnostic of endothelial function by Angioscan

We use electrocardiography, echocardiography with the determination of global longitudinal strain, cardiopulmonary exercise test, and diagnostic of endothelial function by Angioscan for the prediction of cardiovascular complications after high dose chemotherapy and hematopoietic cell transplantation in patients with haemoblasts.

Trial Locations (1)

Unknown

Sechenov University, Moscow

All Listed Sponsors

lead

I.M. Sechenov First Moscow State Medical University

OTHER